The New Role of SGLT2 Inhibitors in the Management of Heart Failure: Current Evidence and Future Perspective

The sodium-glucose transporter 2 inhibitors (SGLT2i) are a relatively new class of medication used in the management of type 2 diabetes. Recent clinical trials and research have demonstrated this class’s effectiveness in treating heart failure, since they reduce the risk of cardiovascular events, ho...

Descripción completa

Detalles Bibliográficos
Autores principales: Muscoli, Saverio, Barillà, Francesco, Tajmir, Rojin, Meloni, Marco, Della Morte, David, Bellia, Alfonso, Di Daniele, Nicola, Lauro, Davide, Andreadi, Aikaterini
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9416279/
https://www.ncbi.nlm.nih.gov/pubmed/36015359
http://dx.doi.org/10.3390/pharmaceutics14081730

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9416279/
https://www.ncbi.nlm.nih.gov/pubmed/36015359
http://dx.doi.org/10.3390/pharmaceutics14081730

Ejemplares similares